Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.27.761507

Pedigree-tracking improved population monitoring of recessive disease-causing alleles in pedigreed canine populations

Abstract

Background Most monogenic inherited diseases in dogs are recessive, so their successful control depends on genetic testing to identify carriers of the disease-causing allele. However, currently used methods for disease allele monitoring in canine populations typically only consider part of the entire pedigree, since not all dogs have a known genotype through genetic test or "hereditary status" (a determinable genotype assigned to offspring based on known parental genotypes). Methods This study uses probabilistic inference with unknown parent groups (UPGs) in five Royal Kennel Club (RKC)-registered pedigrees to estimate genotype probabilities for all individuals using available genetic test results for two monogenic recessive diseases: primary lens luxation (PLL) and progressive retinal atrophy rod-cone degeneration 4 (PRA-rcd4). From these estimates, the population trends in disease-causing allele frequencies were estimated, and the inference quality was assessed through leave-one-out cross-validation and simulation. Results For dogs born after the introduction of the genetic test, the estimated disease-causing allele frequencies differed between methods. For instance, dogs born in 2020 reported up to 0.092 higher disease-causing allele frequencies with estimated genotype probabilities than those based on genetic tests and hereditary status alone. Inference performance varied across breeds, dependent on population allele frequency, with Pearson correlations between true (per genetic test result) and estimated allele dosages ranging from 0.47 to 0.67. The gene drop simulations indicated a tendency to underestimate disease-causing allele frequencies in retrospective estimates, particularly for dogs born before 1990. Impact Overall, by leveraging all available pedigree and genetic test data through probabilistic pedigree-based inference, disease-causing allele frequencies were monitored more comprehensively within the pedigreed population rather than relying on genetic test results or hereditary status alone. Such monitoring can inform responsible breeding decisions, helping to conserve genetic diversity whilst supporting improvements in future canine health and welfare.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Craddock, R. F., Janes Fistric, M., Mellersh, C., Ilska, J. J., Wiener, P., Smith, S., Gorjanc, G.. 2026-10-29. Pedigree-tracking improved population monitoring of recessive disease-causing alleles in pedigreed canine populations. https://doi.org/10.64898/2026.10.27.761507

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Human infection with an ape Plasmodium vivax-like parasite

An unusually divergent Plasmodium vivax parasite was reported in a Swedish patient with recent travel. Using whole-genome sequencing, we show that the infection was caused by a strain of ape P. vivax-like, providing evidence of the zoonotic potential of these parasites that infect wild gorillas and chimpanzees in central Africa.

genetics↗

Preclinical Development and Safety of Laterally Spreading Dual AAV.SPR-MYO7A Vectors for the Treatment of Usher Syndrome Type 1B

Usher syndrome type 1B (USH1B), caused by mutations in MYO7A, is the most severe form of Usher syndrome and accounts for more than 50% of USH1 cases. Affected patients are born profoundly deaf with vestibular dysfunction and develop progressive retinitis pigmentosa, for which no approved treatment exists. The MYO7A coding sequence exceeds the packaging capacity of adeno-associated virus (AAV), the gold standard vector for retinal gene therapy. To overcome this, we developed dual AAV hybrid and overlap platforms to reconstitute full-length MYO7A expression in photoreceptors and retinal pigment epithelium. Modification of cDNA split points, and reduction of non-coding sequence yielded optimized vector pairs that produced higher full-length MYO7A levels with substantially reduced truncated protein. Packaging in the laterally spreading AAV.SPR capsid enabled supraphysiological MYO7A expression in cynomolgus macaques at macular and distal retinal sites without requiring foveal detachment, an important safety consideration for USH1B patients with remaining central vision. A six-month GLP toxicology study confirmed that ATSN-301, an AAV.SPR-based dual vector reconstituting MYO7A driven by the smCBA promoter, was well tolerated at all doses, with a No Observed Adverse Effect Level established at 1.2E11 vg/eye, supporting its clinical advancement for USH1B.

genetics↗

High-resolution HLA and MICA/MICB typing of the 1000 Genomes panel: a resource for precision medicine

High-resolution characterization of human leukocyte antigen (HLA) and MICA/MICB variation is important for transplantation, immunogenetics, and the interpretation of disease associations within the major histocompatibility complex (MHC). However, publicly available population reference datasets remain limited in their resolution and coverage of these loci. We performed high-resolution typing of the 1000 Genomes Phase 3 panel across 13 HLA and MIC loci, generating HLA genotypes for 2,486 individuals, extended HLA-A, -B, and -C allele assignments, and MICA/MICB genotypes for 2,393 individuals representing 25 populations and five continental super-populations. Concordance with previously reported HLA genotypes was 96.2-97.4% at two-field resolution, and independent retyping confirmed the present assignments for samples exhibiting reciprocal genotype discrepancies with an earlier dataset. Analysis of extended class I variation within defined assay boundaries revealed that most of the 78 common three-field HLA lineages were dominated by a single extended sequence group. However, eleven lineages exhibited substantial heterogeneity, with the predominant group accounting for less than 80% of observed copies. The distinguishing sequence differences were noncoding, involving intronic and 3' untranslated regions, and their distributions varied among ancestral populations. These findings identify recurrent, population-relevant variants for which functional consequences remain to be established. Population analyses demonstrated extensive allelic diversity at classical class I loci and DRB1, whereas the greatest between-population differentiation occurred at selected class II and DRB-linked loci. Most common alleles were shared among populations but differed substantially in frequency. Multilocus haplotypes revealed characteristic population-associated combinations of HLA and MIC alleles and provided the basis for predicting MIC genotypes from existing HLA typing. Using two-field HLA-B and HLA-C genotypes, five-fold cross-validation achieved exact genotype prediction accuracies of 77.3% for MICA and 53.6% for MICB, compared with 4.6% and 21.6%, respectively, without HLA information. Together, these results provide an extended-resolution HLA and MIC reference resource, demonstrate the limited routine utility of universal fourth-field typing while identifying specific variants for functional investigation, and establish the potential for recovering MIC variation from existing HLA-typed cohorts. The resource also supports future investigations of MHC variation underlying disease associations and transplantation outcomes.

genetics↗